drugset / Trial / NCT00216229
Twinrix Alternative Schedule Study
RandomizedParallel-groupOpen-labelPrevention
Summary
To compare the efficiency of protection against hepatitis-B virus by administration of the combined vaccine against hepatitis A and B using the schedule 0-1-12 months against the schedule 0-1-6 months. 1. To compare the seroconversion (\>= 1 IU/l) and seroprotection (\>= 10 IU/l) rate at month 6,7,12 and 13. 2. To compare the distribution of anti-HBs at these different moments.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Twinrix | Vaccine | — | — |
Indications
No indication recorded.